The global surrogacy market reached a size of USD 204.6 Million in 2025 and is projected to expand to USD 329.2 Million by 2034, growing at a CAGR of 5.43% during 2026-2034. Market growth is fueled by rising infertility rates, increased societal acceptance of surrogacy, advancements in assisted reproductive technologies, and favorable government payment policies. The market is also impacted by fertility tourism and legal frameworks supporting surrogacy. 

Study Assumption Years

• Base Year: 2025

• Historical Years: 2020-2025

• Forecast Period: 2026-2034

Surrogacy Market Key Takeaways

• The global surrogacy market size was valued at USD 194.0 Million in 2024.

• The market is expected to exhibit a CAGR of 5.43% during 2026-2034.

• The forecast period for this report is from 2026 to 2034.

• Growth is driven by the increasing prevalence of infertility, growing awareness and acceptance of surrogacy, and legal developments creating transparent safeguards.

• Advances in IVF treatments have increased success rates, fueling the demand.

• North America dominates due to its supportive legal framework, advanced medical facilities, and high public acceptance.

• Fertility clinics are the leading service providers, offering comprehensive surrogacy services and supporting medical innovation.

Sample Request Link: 

https://www.imarcgroup.com/surrogacy-market/requestsample

Market Growth Factors

One of the primary growth drivers of the surrogacy market is the steady rise in infertility cases worldwide. Factors such as changing lifestyles, high stress levels, obesity, smoking, alcohol consumption, and exposure to environmental pollutants are negatively affecting reproductive health among both men and women. Additionally, delayed parenthood due to career priorities, late marriages, and financial planning has increased age-related fertility complications. As natural conception becomes more challenging for older couples, surrogacy emerges as a reliable alternative. This trend is particularly strong in urban and developed regions, where awareness, affordability, and access to assisted reproductive technologies are higher.

Continuous technological progress in assisted reproductive technologies is significantly boosting the surrogacy market. Innovations such as improved in-vitro fertilization success rates, embryo screening, cryopreservation, and advanced hormonal therapies have enhanced pregnancy outcomes while minimizing health risks for surrogates and intended parents. Technologies like IVF with ICSI enable successful fertilization even in cases of severe male infertility, expanding the eligible patient pool. These advancements have improved clinical confidence, reduced failure rates, and increased acceptance of surrogacy as a medically viable solution. As fertility clinics invest in cutting-edge infrastructure, treatment success and patient trust continue to rise.

Increasing social acceptance of non-traditional family structures is another major factor propelling market growth. Greater awareness, advocacy, and normalization of surrogacy among single parents, same-sex couples, and infertile couples have expanded demand. In parallel, several countries are establishing clearer legal and regulatory frameworks to protect the rights of surrogates, children, and intended parents, improving market transparency. Moreover, the rise of fertility-focused medical tourism, driven by cost advantages, advanced healthcare infrastructure, and skilled specialists in certain regions, is accelerating cross-border surrogacy arrangements and supporting sustained global market expansion.

Market Segmentation

By Type

• Gestational Surrogacy: This segment dominates the market, involving a surrogate carrying a pregnancy genetically unrelated to her, offering benefits in reducing legal and psychological challenges. It caters to individuals and couples with reproductive issues or same-sex couples, driven by advancements in IVF accuracy increasing success rates.

• Traditional Surrogacy: Included as a segment but less dominant than gestational surrogacy.

By Technology

• IVF with ICSI: This segment holds the largest market share, employing intracytoplasmic sperm injection to overcome male infertility by injecting a single sperm directly into an egg, enhancing fertilization success and extending surrogacy applicability.

• IVF without ICSI: Present as a segment.

• Intrauterine Insemination: Included as a segment.

By Service Provider

• Fertility Clinics: The largest segment, fertility clinics provide advanced reproductive technologies, full medical assessments, and comprehensive treatment and monitoring, collaborating closely with legal and surrogacy agencies to facilitate successful pregnancies.

• Hospitals: Included as a segment.

• Others: Included as a segment.

Regional Insights

North America leads the surrogacy market, driven by a strong legal framework protecting intended parents, surrogates, and resultant children. The region's advanced fertility treatment centers, high success and safety rates, and broad public acceptance position it as the dominant market globally. The multi-ethnic population and evolving perceptions of family contribute to sustained growth and attractiveness for domestic and international intended parents.

Recent Developments & News

In June 2021, Circle Surrogacy & Egg Donation launched the "A Lifetime of Pride and Joy" campaign to promote family equality and fertility care accessibility for the LGBTQ+ community. In June 2023, Nova IVF Fertility announced a plan to expand to 100 centers across India in four years, enhancing access to fertility care. In October 2022, Ovation Fertility partnered with Genomic Prediction to advance genetic testing capabilities for fertility and family planning.

Key Players

• Bourn Hall Fertility Clinic

• Care Fertility

• Circle Surrogacy

• Extraordinary Conceptions

• Growing Generations

• Houston Fertility Center

• IVIRMA Global

• Kindbody

• Max Healthcare

• New Hope Fertility Clinic

• Nova IVF

• Ovation Fertility

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5298&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302